touchpodcast
touchPODCAST
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005!We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updatesHome...
No dejes de visitar la web del podcast y apoyar a su creador: touchpodcast.podbean.com
Autor
touchpodcast
Categoría
Web del podcast
Último episodio
16 de oct. de 2026
¿Dónde escuchar?
Podcasts en la app Replaio Radio Muy prontoLos podcasts llegarán muy pronto a la app. Instálala ahora y sé el primero en descubrir una forma totalmente nueva de vivir los podcasts
Episodios
DOACs and reversal agents for patients experiencing ICH: Latest evidence - touchCARDIOLOGY 10.08.2023 36:02
touchEXPERT OPINIONS for touchCARDIOLOGY Leading experts share their insights on the impact of intracerebral haemorrhage (ICH) in patients receiving direct oral anticoagulants (DOACs), DOAC-ICH reversal agents and optimizing treatment outcomes. The experts: Prof. Hanne Christensen, University of Copenhagen, Denmark Prof. Thorsten Steiner, The Clinical Centre in Frankfurt Höchst, Frankfurt, Germany...
DOACs and reversal agents for patients experiencing ICH: Latest evidence - touchNEUROLOGY 10.08.2023 36:01
touchEXPERT OPINIONS for touchNEUROLOGY Leading experts share their insights on the impact of intracerebral haemorrhage (ICH) in patients receiving direct oral anticoagulants (DOACs), DOAC-ICH reversal agents and optimizing treatment outcomes. The experts: Prof. Hanne Christensen, University of Copenhagen, Denmark Prof. Thorsten Steiner, The Clinical Centre in Frankfurt Höchst, Frankfurt, Germany...
Key considerations in the management of irAEs with ICIs in advanced or recurrent endometrial cancer 09.08.2023 15:08
touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the case-based implementation of immune checkpoint inhibitors in endometrial cancer through shared decision making. The multidisciplinary team: Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria Medical oncologist: Dr Ilaria Colombo, Bellinzona, Switzerland This touchPODCAST is for HCPs only. T...
Importance of shared decision making in the management of endometrial cancer 09.08.2023 12:10
touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss key considerations in the management of immune-related adverse events with immune checkpoint inhibitors in advanced or recurrent endometrial cancer The multidisciplinary team: Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria Medical oncologist: Dr Ilaria Colombo, Bellinzona, Switzerland Patho...
Improving outcomes with ICIs in advanced or recurrent endometrial cancer 09.08.2023 14:31
touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss improving outcomes with immune checkpoint inhibitors in advanced or recurrent endometrial cancer. The multidisciplinary team: Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria Medical oncologist: Dr Ilaria Colombo, Bellinzona, Switzerland This touchPODCAST is for HCPs only. This activity is fu...
Optimizing outcomes of JAK inhibition in myelofibrosis: Practical considerations for the clinic - touchHAEMATOLOGY 31.07.2023 35:07
touchIN CONVERSATION for touchHAEMATOLOGY Listen to Prof. John Mascarenhas (Icahn School of Medicine at Mount Sinai, New York, NY, USA) in conversation with Dr Raajit Rampal (Memorial Sloan Kettering Cancer Center, New York, NY, USA) on how to optimize the use of JAK inhibitors for patients with myelofibrosis. They respond to questions submitted by the HCP audience and provide expert insights on:...
Optimizing outcomes of JAK inhibition in myelofibrosis: Practical considerations for the clinic - touchONCOLOGY 31.07.2023 35:06
touchIN CONVERSATION for touchONCOLOGY Listen to Prof. John Mascarenhas (Icahn School of Medicine at Mount Sinai, New York, NY, USA) in conversation with Dr Raajit Rampal (Memorial Sloan Kettering Cancer Center, New York, NY, USA) on how to optimize the use of JAK inhibitors for patients with myelofibrosis. They respond to questions submitted by the HCP audience and provide expert insights on: T...
Preventing HPV-associated cancer by maximizing vaccine uptake 31.07.2023 35:21
touchPANEL DISCUSSION for touchINFECTIOUS DISEASES Listen to a panel of leading experts discuss the importance of HPV vaccination in preventing HPV-associated cancers, World Health Organization guidance on vaccine eligibility and scheduling, as well as strategies to improve HPV vaccination uptake. The experts: Prof. Lynette Denny GCOB (Silver), University of Cape Town, Cape Town, South Africa, Pr...
Preventing HPV-associated cancer by maximizing vaccine uptake 31.07.2023 35:20
touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the importance of HPV vaccination in preventing HPV-associated cancers, World Health Organization guidance on vaccine eligibility and scheduling, as well as strategies to improve HPV vaccination uptake. The experts: Prof. Lynette Denny GCOB (Silver), University of Cape Town, Cape Town, South Africa, Prof. Eduardo...
Fulfilling the potential of HER2-targeting in colorectal cancer 26.07.2023 36:26
touchEXPERT OPINIONS for touchONCOLOGY Listen to three leading experts provide their insights on detection methods for HER2 amplification, as well as the clinical efficacy data for guideline-recommended HER2-targeted therapies and emerging HER2-targeted therapies for patients with metastatic colorectal cancer. The experts Dr Andrew Wotherspoon - Royal Marsden Hospital, London, UK; Dr Andrea Cerce...
Migraine prevention in the real world: Exploring the role of anti-CGRP antibodies - Modules 1 & 2 20.07.2023 33:15
touchCLINICAL PERSPECTIVES for touchNEUROLOGY - Module 1 & 2 Module 1 Listen first to an expert provide their insights on the burden of migraine for patients, the need for effective preventive therapy and the currently available preventive treatment options. The expert Professor Simona Sacco - University of L’Aquila, Italy Module 2 Listen next to a patient advocate providing her insights on t...
Advancing the management of adult solid tumours in 2023, and beyond: Unlocking the potential of radiopharmaceuticals 18.07.2023 55:59
touchEXPERT OPINIONS for touchENDOCRINOLOGY Leading experts share their insights on the role and use of radiopharmaceuticals in adult patients with solid tumours (with a focus on NETs and prostate cancer) and provide guidance for daily clinical practice to support their integration. The experts: Part 1 (00:00) Dr Stephen Graves, University of Iowa, Iowa City, IA, USA Dr Ana Kiess, Johns Hopkins Un...
Advancing the management of adult solid tumours in 2023, and beyond: Unlocking the potential of radiopharmaceuticals 18.07.2023 55:59
touchEXPERT OPINIONS for touchONCOLOGY Leading experts share their insights on the role and use of radiopharmaceuticals in adult patients with solid tumours (with a focus on NETs and prostate cancer) and provide guidance for daily clinical practice to support their integration. The experts: Part 1 (00:00) Dr Stephen Graves, University of Iowa, Iowa City, IA, USA Dr Ana Kiess, Johns Hopkins Univers...
Current and future considerations for the use of immune checkpoint inhibitors in NSCLC 10.07.2023 33:15
Listen to a leading expert discuss the use of immune checkpoint inhibitors for the treatment of NSCLC, considering the current landscape and future perspectives. The expert Dr Pilar Garrido – University Hospital Ramón y Cajal, Madrid, Spain This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck and Co., Inc. This activity is jointly provide...
Current and future considerations for the use of immune checkpoint inhibitors in NSCLC 10.07.2023 33:16
Listen to a leading expert discuss the use of immune checkpoint inhibitors for the treatment of NSCLC, considering the current landscape and future perspectives. The expert Dr Pilar Garrido – University Hospital Ramón y Cajal, Madrid, Spain This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck and Co., Inc. This activity is jointly provide...
Shaping ART around individual needs: Maximizing adherence and quality of life 29.06.2023 38:20
touchPANEL DISCUSSION for touchINFECTIOUS DISEASES Listen to a panel of experts discuss the importance of optimizing antiretroviral therapy through an individualized approach to care and shared decision making. The experts Prof Jens Lundgren, University of Copenhagen, Hvidovre, Denmark Prof Marta Boffito, Chelsea and Westminster Hospital and Imperial College London, UK Ms Angelina Namiba, 4M Netw...
Latest developments in neuromyelitis optica spectrum disorder (NMOSD): Diagnostics, treatments and patient-centered care 22.06.2023 50:15
touchSATELLITE SYMPOSIUM for touchOPHTHALMOLOGY Listen to this touch satellite symposium recorded live in June 2023 at the Annual Meeting of the Consortium of Multiple Sclerosis Centers. Dr Dalia Rotstein (Canada), the chair for the symposium, is joined by Dr Eoin Flanagan (USA) and Dr Jeffrey Bennett (USA). The first session, led by Dr Eoin Flanagan (03:55), focuses on the characterization of NMO...
Latest developments in neuromyelitis optica spectrum disorder (NMOSD): Diagnostics, treatments and patient-centered care 22.06.2023 50:15
touchSATELLITE SYMPOSIUM for touchNEUROLOGY Listen to this touch satellite symposium recorded live in June 2023 at the Annual Meeting of the Consortium of Multiple Sclerosis Centers. Dr Dalia Rotstein (Canada), the chair for the symposium, is joined by Dr Eoin Flanagan (USA) and Dr Jeffrey Bennett (USA). The first session, led by Dr Eoin Flanagan (03:55), focuses on the characterization of NMOSD,...
Key considerations for treatment selection and sequencing in patients with RRMM: Lessons from real-life clinical practice 21.06.2023 39:32
touchPANEL DISCUSSION for touchHAEMATOLOGY Listen to a panel of leading experts discuss the key considerations for treatment selection and sequencing in patients with RRMM. The experts: Dr Sarah Holstein, University of Nebraska Medical Center, Omaha, NE, USA Dr Nikhil Munshi, Dana-Farber Cancer Institute, Boston, MA, USA Dr Noopur Raje, Massachusetts General Hospital and Harvard Medical School, Bo...
Key considerations for treatment selection and sequencing in patients with RRMM Lessons from real-life clinical practice 21.06.2023 39:32
touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the key considerations for treatment selection and sequencing in patients with RRMM. The experts: Dr Sarah Holstein, University of Nebraska Medical Center, Omaha, NE, USA Dr Nikhil Munshi, Dana-Farber Cancer Institute, Boston, MA, USA Dr Noopur Raje, Massachusetts General Hospital and Harvard Medical School, Bost...
Individualizing long-term treatment and care in active MS 12.06.2023 36:26
touchIN CONVERSATION for touchNEUROLOGY Listen to Dr Ruth Dobson (Queen Mary University of London, UK) in conversation with Dr Ide Smets (MS Center ErasMS, Rotterdam, The Netherlands). They discuss questions submitted by the healthcare professional (HCP) audience and provide their expert insights on the practicalities of therapeutic sequencing options in multiple sclerosis (MS). Clinical themes: F...
MDT perspectives on approaches for the use of immune checkpoint inhibitor therapy in patients with solid tumours 08.06.2023 11:35
touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team evaluate the strategies for identifying and monitoring immune-related adverse events. The multidisciplinary team: Medical oncologist: Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan Oncology nurse: Ms Tara Hurley, Royal Marsden NHS Foundation Trust, Sutton, UK Clinical oncology pharmacist: Dr Alison Palumb...
MDT perspectives on the role of biomarkers in informing immune checkpoint inhibitor use across tumour types 08.06.2023 12:32
touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team review the role of biomarkers in informing immune checkpoint inhibitor use across tumour types. The multidisciplinary team Medical oncologist: Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan Pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Heidelberg, Germany This touchPODCAST is for...
MDT perspectives on strategies for identifying and monitoring immune-related adverse events 08.06.2023 12:12
touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team evaluate the strategies for identifying and monitoring immune-related adverse events. The multidisciplinary team: Medical oncologist: Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan Oncology nurse: Ms Tara Hurley, Royal Marsden NHS Foundation Trust, Sutton, UK Clinical oncology pharmacist: Dr Alison Palumb...
MDT perspectives on indications for immune checkpoint inhibitors in patients with solid tumours 08.06.2023 13:25
touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the current and upcoming indications for immune checkpoint inhibitors in patients with solid tumours and review general considerations for their use. The multidisciplinary team: Medical oncologist: Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan Oncology nurse: Ms Tara Hurley, Royal Marsden NHS Fou...
Podcasts similares
Replaio no es editor de podcasts; los nombres de los programas, las portadas y el audio pertenecen a sus autores y se distribuyen a través de canales RSS públicos